Company Freeline Therapeutics Holdings plc
Equities
FRLN
US35655L2060
Biotechnology & Medical Research
Business Summary
Number of employees: 152
Managers
Managers | Title | Age | Since |
---|---|---|---|
Markus Hörer
FOU | Founder | - | 31/12/14 |
Michael Parini
CEO | Chief Executive Officer | 49 | 14/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 15/05/22 |
Chief Tech/Sci/R&D Officer | 57 | 28/02/22 | |
Pamela Foulds
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/10/21 |
James Bircher
COO | Chief Operating Officer | 56 | 30/06/21 |
Naomi Aoki
IRC | Investor Relations Contact | - | - |
Chip McCorkle
LAW | General Counsel | - | - |
Nicole Jones
HRO | Human Resources Officer | 54 | 10/07/22 |
Amy J. Spandau
PRN | Corporate Officer/Principal | - | 31/01/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Hollowood
CHM | Chairman | 50 | 30/11/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 14/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 15/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,369,417 | 64,715,513 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Freeline Therapeutics Holdings Plc
Sycamore House Gunnels Wood Road
SG1 2BP, Stevenage
+44 14 3890 6870
http://www.freeline.lifeSector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |